Global Tianeptine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.
LPI (LP Information)' newest research report, the “Tianeptine Industry Forecast” looks at past sales and reviews total world Tianeptine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tianeptine sales for 2023 through 2029. With Tianeptine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tianeptine industry.
This Insight Report provides a comprehensive analysis of the global Tianeptine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tianeptine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tianeptine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tianeptine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tianeptine.
The global Tianeptine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tianeptine players cover Servier, Lupin Limited, PharmaS, Antibiotice, Serdia Pharmaceuticals, Alvogen, Bausch Health, Genefar B.V. and Arena Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tianeptine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Tianeptine market?
What factors are driving Tianeptine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tianeptine market opportunities vary by end market size?
How does Tianeptine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.
LPI (LP Information)' newest research report, the “Tianeptine Industry Forecast” looks at past sales and reviews total world Tianeptine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tianeptine sales for 2023 through 2029. With Tianeptine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tianeptine industry.
This Insight Report provides a comprehensive analysis of the global Tianeptine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tianeptine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tianeptine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tianeptine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tianeptine.
The global Tianeptine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tianeptine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tianeptine players cover Servier, Lupin Limited, PharmaS, Antibiotice, Serdia Pharmaceuticals, Alvogen, Bausch Health, Genefar B.V. and Arena Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tianeptine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Patent
- Generic
- Depression and Anxiety
- Irritable Bowel Syndrome
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Servier
- Lupin Limited
- PharmaS
- Antibiotice
- Serdia Pharmaceuticals
- Alvogen
- Bausch Health
- Genefar B.V.
- Arena Pharmaceuticals
- Glenmark
- Novartis
- Dongwha Pharm
- Liconsa SA
- Mylan
- Adamed
- Neuraxpharm Arzneimittel
- Grupo Insud
What is the 10-year outlook for the global Tianeptine market?
What factors are driving Tianeptine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tianeptine market opportunities vary by end market size?
How does Tianeptine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tianeptine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tianeptine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tianeptine by Country/Region, 2018, 2022 & 2029
2.2 Tianeptine Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Tianeptine Sales by Type
2.3.1 Global Tianeptine Sales Market Share by Type (2018-2023)
2.3.2 Global Tianeptine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tianeptine Sale Price by Type (2018-2023)
2.4 Tianeptine Segment by Application
2.4.1 Depression and Anxiety
2.4.2 Irritable Bowel Syndrome
2.5 Tianeptine Sales by Application
2.5.1 Global Tianeptine Sale Market Share by Application (2018-2023)
2.5.2 Global Tianeptine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tianeptine Sale Price by Application (2018-2023)
3 GLOBAL TIANEPTINE BY COMPANY
3.1 Global Tianeptine Breakdown Data by Company
3.1.1 Global Tianeptine Annual Sales by Company (2018-2023)
3.1.2 Global Tianeptine Sales Market Share by Company (2018-2023)
3.2 Global Tianeptine Annual Revenue by Company (2018-2023)
3.2.1 Global Tianeptine Revenue by Company (2018-2023)
3.2.2 Global Tianeptine Revenue Market Share by Company (2018-2023)
3.3 Global Tianeptine Sale Price by Company
3.4 Key Manufacturers Tianeptine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tianeptine Product Location Distribution
3.4.2 Players Tianeptine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TIANEPTINE BY GEOGRAPHIC REGION
4.1 World Historic Tianeptine Market Size by Geographic Region (2018-2023)
4.1.1 Global Tianeptine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tianeptine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tianeptine Market Size by Country/Region (2018-2023)
4.2.1 Global Tianeptine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tianeptine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tianeptine Sales Growth
4.4 APAC Tianeptine Sales Growth
4.5 Europe Tianeptine Sales Growth
4.6 Middle East & Africa Tianeptine Sales Growth
5 AMERICAS
5.1 Americas Tianeptine Sales by Country
5.1.1 Americas Tianeptine Sales by Country (2018-2023)
5.1.2 Americas Tianeptine Revenue by Country (2018-2023)
5.2 Americas Tianeptine Sales by Type
5.3 Americas Tianeptine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tianeptine Sales by Region
6.1.1 APAC Tianeptine Sales by Region (2018-2023)
6.1.2 APAC Tianeptine Revenue by Region (2018-2023)
6.2 APAC Tianeptine Sales by Type
6.3 APAC Tianeptine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tianeptine by Country
7.1.1 Europe Tianeptine Sales by Country (2018-2023)
7.1.2 Europe Tianeptine Revenue by Country (2018-2023)
7.2 Europe Tianeptine Sales by Type
7.3 Europe Tianeptine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tianeptine by Country
8.1.1 Middle East & Africa Tianeptine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tianeptine Revenue by Country (2018-2023)
8.2 Middle East & Africa Tianeptine Sales by Type
8.3 Middle East & Africa Tianeptine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tianeptine
10.3 Manufacturing Process Analysis of Tianeptine
10.4 Industry Chain Structure of Tianeptine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tianeptine Distributors
11.3 Tianeptine Customer
12 WORLD FORECAST REVIEW FOR TIANEPTINE BY GEOGRAPHIC REGION
12.1 Global Tianeptine Market Size Forecast by Region
12.1.1 Global Tianeptine Forecast by Region (2024-2029)
12.1.2 Global Tianeptine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tianeptine Forecast by Type
12.7 Global Tianeptine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Tianeptine Product Portfolios and Specifications
13.1.3 Servier Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Lupin Limited
13.2.1 Lupin Limited Company Information
13.2.2 Lupin Limited Tianeptine Product Portfolios and Specifications
13.2.3 Lupin Limited Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lupin Limited Main Business Overview
13.2.5 Lupin Limited Latest Developments
13.3 PharmaS
13.3.1 PharmaS Company Information
13.3.2 PharmaS Tianeptine Product Portfolios and Specifications
13.3.3 PharmaS Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 PharmaS Main Business Overview
13.3.5 PharmaS Latest Developments
13.4 Antibiotice
13.4.1 Antibiotice Company Information
13.4.2 Antibiotice Tianeptine Product Portfolios and Specifications
13.4.3 Antibiotice Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Antibiotice Main Business Overview
13.4.5 Antibiotice Latest Developments
13.5 Serdia Pharmaceuticals
13.5.1 Serdia Pharmaceuticals Company Information
13.5.2 Serdia Pharmaceuticals Tianeptine Product Portfolios and Specifications
13.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serdia Pharmaceuticals Main Business Overview
13.5.5 Serdia Pharmaceuticals Latest Developments
13.6 Alvogen
13.6.1 Alvogen Company Information
13.6.2 Alvogen Tianeptine Product Portfolios and Specifications
13.6.3 Alvogen Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alvogen Main Business Overview
13.6.5 Alvogen Latest Developments
13.7 Bausch Health
13.7.1 Bausch Health Company Information
13.7.2 Bausch Health Tianeptine Product Portfolios and Specifications
13.7.3 Bausch Health Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bausch Health Main Business Overview
13.7.5 Bausch Health Latest Developments
13.8 Genefar B.V.
13.8.1 Genefar B.V. Company Information
13.8.2 Genefar B.V. Tianeptine Product Portfolios and Specifications
13.8.3 Genefar B.V. Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Genefar B.V. Main Business Overview
13.8.5 Genefar B.V. Latest Developments
13.9 Arena Pharmaceuticals
13.9.1 Arena Pharmaceuticals Company Information
13.9.2 Arena Pharmaceuticals Tianeptine Product Portfolios and Specifications
13.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Arena Pharmaceuticals Main Business Overview
13.9.5 Arena Pharmaceuticals Latest Developments
13.10 Glenmark
13.10.1 Glenmark Company Information
13.10.2 Glenmark Tianeptine Product Portfolios and Specifications
13.10.3 Glenmark Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Glenmark Main Business Overview
13.10.5 Glenmark Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Tianeptine Product Portfolios and Specifications
13.11.3 Novartis Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Dongwha Pharm
13.12.1 Dongwha Pharm Company Information
13.12.2 Dongwha Pharm Tianeptine Product Portfolios and Specifications
13.12.3 Dongwha Pharm Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dongwha Pharm Main Business Overview
13.12.5 Dongwha Pharm Latest Developments
13.13 Liconsa SA
13.13.1 Liconsa SA Company Information
13.13.2 Liconsa SA Tianeptine Product Portfolios and Specifications
13.13.3 Liconsa SA Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Liconsa SA Main Business Overview
13.13.5 Liconsa SA Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Tianeptine Product Portfolios and Specifications
13.14.3 Mylan Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 Adamed
13.15.1 Adamed Company Information
13.15.2 Adamed Tianeptine Product Portfolios and Specifications
13.15.3 Adamed Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Adamed Main Business Overview
13.15.5 Adamed Latest Developments
13.16 Neuraxpharm Arzneimittel
13.16.1 Neuraxpharm Arzneimittel Company Information
13.16.2 Neuraxpharm Arzneimittel Tianeptine Product Portfolios and Specifications
13.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Neuraxpharm Arzneimittel Main Business Overview
13.16.5 Neuraxpharm Arzneimittel Latest Developments
13.17 Grupo Insud
13.17.1 Grupo Insud Company Information
13.17.2 Grupo Insud Tianeptine Product Portfolios and Specifications
13.17.3 Grupo Insud Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Grupo Insud Main Business Overview
13.17.5 Grupo Insud Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tianeptine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tianeptine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tianeptine by Country/Region, 2018, 2022 & 2029
2.2 Tianeptine Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Tianeptine Sales by Type
2.3.1 Global Tianeptine Sales Market Share by Type (2018-2023)
2.3.2 Global Tianeptine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tianeptine Sale Price by Type (2018-2023)
2.4 Tianeptine Segment by Application
2.4.1 Depression and Anxiety
2.4.2 Irritable Bowel Syndrome
2.5 Tianeptine Sales by Application
2.5.1 Global Tianeptine Sale Market Share by Application (2018-2023)
2.5.2 Global Tianeptine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tianeptine Sale Price by Application (2018-2023)
3 GLOBAL TIANEPTINE BY COMPANY
3.1 Global Tianeptine Breakdown Data by Company
3.1.1 Global Tianeptine Annual Sales by Company (2018-2023)
3.1.2 Global Tianeptine Sales Market Share by Company (2018-2023)
3.2 Global Tianeptine Annual Revenue by Company (2018-2023)
3.2.1 Global Tianeptine Revenue by Company (2018-2023)
3.2.2 Global Tianeptine Revenue Market Share by Company (2018-2023)
3.3 Global Tianeptine Sale Price by Company
3.4 Key Manufacturers Tianeptine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tianeptine Product Location Distribution
3.4.2 Players Tianeptine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TIANEPTINE BY GEOGRAPHIC REGION
4.1 World Historic Tianeptine Market Size by Geographic Region (2018-2023)
4.1.1 Global Tianeptine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tianeptine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tianeptine Market Size by Country/Region (2018-2023)
4.2.1 Global Tianeptine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tianeptine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tianeptine Sales Growth
4.4 APAC Tianeptine Sales Growth
4.5 Europe Tianeptine Sales Growth
4.6 Middle East & Africa Tianeptine Sales Growth
5 AMERICAS
5.1 Americas Tianeptine Sales by Country
5.1.1 Americas Tianeptine Sales by Country (2018-2023)
5.1.2 Americas Tianeptine Revenue by Country (2018-2023)
5.2 Americas Tianeptine Sales by Type
5.3 Americas Tianeptine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tianeptine Sales by Region
6.1.1 APAC Tianeptine Sales by Region (2018-2023)
6.1.2 APAC Tianeptine Revenue by Region (2018-2023)
6.2 APAC Tianeptine Sales by Type
6.3 APAC Tianeptine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tianeptine by Country
7.1.1 Europe Tianeptine Sales by Country (2018-2023)
7.1.2 Europe Tianeptine Revenue by Country (2018-2023)
7.2 Europe Tianeptine Sales by Type
7.3 Europe Tianeptine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tianeptine by Country
8.1.1 Middle East & Africa Tianeptine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tianeptine Revenue by Country (2018-2023)
8.2 Middle East & Africa Tianeptine Sales by Type
8.3 Middle East & Africa Tianeptine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tianeptine
10.3 Manufacturing Process Analysis of Tianeptine
10.4 Industry Chain Structure of Tianeptine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tianeptine Distributors
11.3 Tianeptine Customer
12 WORLD FORECAST REVIEW FOR TIANEPTINE BY GEOGRAPHIC REGION
12.1 Global Tianeptine Market Size Forecast by Region
12.1.1 Global Tianeptine Forecast by Region (2024-2029)
12.1.2 Global Tianeptine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tianeptine Forecast by Type
12.7 Global Tianeptine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Tianeptine Product Portfolios and Specifications
13.1.3 Servier Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Lupin Limited
13.2.1 Lupin Limited Company Information
13.2.2 Lupin Limited Tianeptine Product Portfolios and Specifications
13.2.3 Lupin Limited Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lupin Limited Main Business Overview
13.2.5 Lupin Limited Latest Developments
13.3 PharmaS
13.3.1 PharmaS Company Information
13.3.2 PharmaS Tianeptine Product Portfolios and Specifications
13.3.3 PharmaS Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 PharmaS Main Business Overview
13.3.5 PharmaS Latest Developments
13.4 Antibiotice
13.4.1 Antibiotice Company Information
13.4.2 Antibiotice Tianeptine Product Portfolios and Specifications
13.4.3 Antibiotice Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Antibiotice Main Business Overview
13.4.5 Antibiotice Latest Developments
13.5 Serdia Pharmaceuticals
13.5.1 Serdia Pharmaceuticals Company Information
13.5.2 Serdia Pharmaceuticals Tianeptine Product Portfolios and Specifications
13.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serdia Pharmaceuticals Main Business Overview
13.5.5 Serdia Pharmaceuticals Latest Developments
13.6 Alvogen
13.6.1 Alvogen Company Information
13.6.2 Alvogen Tianeptine Product Portfolios and Specifications
13.6.3 Alvogen Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alvogen Main Business Overview
13.6.5 Alvogen Latest Developments
13.7 Bausch Health
13.7.1 Bausch Health Company Information
13.7.2 Bausch Health Tianeptine Product Portfolios and Specifications
13.7.3 Bausch Health Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bausch Health Main Business Overview
13.7.5 Bausch Health Latest Developments
13.8 Genefar B.V.
13.8.1 Genefar B.V. Company Information
13.8.2 Genefar B.V. Tianeptine Product Portfolios and Specifications
13.8.3 Genefar B.V. Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Genefar B.V. Main Business Overview
13.8.5 Genefar B.V. Latest Developments
13.9 Arena Pharmaceuticals
13.9.1 Arena Pharmaceuticals Company Information
13.9.2 Arena Pharmaceuticals Tianeptine Product Portfolios and Specifications
13.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Arena Pharmaceuticals Main Business Overview
13.9.5 Arena Pharmaceuticals Latest Developments
13.10 Glenmark
13.10.1 Glenmark Company Information
13.10.2 Glenmark Tianeptine Product Portfolios and Specifications
13.10.3 Glenmark Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Glenmark Main Business Overview
13.10.5 Glenmark Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Tianeptine Product Portfolios and Specifications
13.11.3 Novartis Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Dongwha Pharm
13.12.1 Dongwha Pharm Company Information
13.12.2 Dongwha Pharm Tianeptine Product Portfolios and Specifications
13.12.3 Dongwha Pharm Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dongwha Pharm Main Business Overview
13.12.5 Dongwha Pharm Latest Developments
13.13 Liconsa SA
13.13.1 Liconsa SA Company Information
13.13.2 Liconsa SA Tianeptine Product Portfolios and Specifications
13.13.3 Liconsa SA Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Liconsa SA Main Business Overview
13.13.5 Liconsa SA Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Tianeptine Product Portfolios and Specifications
13.14.3 Mylan Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 Adamed
13.15.1 Adamed Company Information
13.15.2 Adamed Tianeptine Product Portfolios and Specifications
13.15.3 Adamed Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Adamed Main Business Overview
13.15.5 Adamed Latest Developments
13.16 Neuraxpharm Arzneimittel
13.16.1 Neuraxpharm Arzneimittel Company Information
13.16.2 Neuraxpharm Arzneimittel Tianeptine Product Portfolios and Specifications
13.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Neuraxpharm Arzneimittel Main Business Overview
13.16.5 Neuraxpharm Arzneimittel Latest Developments
13.17 Grupo Insud
13.17.1 Grupo Insud Company Information
13.17.2 Grupo Insud Tianeptine Product Portfolios and Specifications
13.17.3 Grupo Insud Tianeptine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Grupo Insud Main Business Overview
13.17.5 Grupo Insud Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tianeptine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tianeptine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Tianeptine Sales by Type (2018-2023) & (K Units)
Table 6. Global Tianeptine Sales Market Share by Type (2018-2023)
Table 7. Global Tianeptine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tianeptine Revenue Market Share by Type (2018-2023)
Table 9. Global Tianeptine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Tianeptine Sales by Application (2018-2023) & (K Units)
Table 11. Global Tianeptine Sales Market Share by Application (2018-2023)
Table 12. Global Tianeptine Revenue by Application (2018-2023)
Table 13. Global Tianeptine Revenue Market Share by Application (2018-2023)
Table 14. Global Tianeptine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Tianeptine Sales by Company (2018-2023) & (K Units)
Table 16. Global Tianeptine Sales Market Share by Company (2018-2023)
Table 17. Global Tianeptine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tianeptine Revenue Market Share by Company (2018-2023)
Table 19. Global Tianeptine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Tianeptine Producing Area Distribution and Sales Area
Table 21. Players Tianeptine Products Offered
Table 22. Tianeptine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tianeptine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Tianeptine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tianeptine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tianeptine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tianeptine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Tianeptine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tianeptine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tianeptine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tianeptine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Tianeptine Sales Market Share by Country (2018-2023)
Table 35. Americas Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tianeptine Revenue Market Share by Country (2018-2023)
Table 37. Americas Tianeptine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Tianeptine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Tianeptine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Tianeptine Sales Market Share by Region (2018-2023)
Table 41. APAC Tianeptine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tianeptine Revenue Market Share by Region (2018-2023)
Table 43. APAC Tianeptine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Tianeptine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Tianeptine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Tianeptine Sales Market Share by Country (2018-2023)
Table 47. Europe Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tianeptine Revenue Market Share by Country (2018-2023)
Table 49. Europe Tianeptine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Tianeptine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Tianeptine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Tianeptine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tianeptine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tianeptine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Tianeptine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tianeptine
Table 58. Key Market Challenges & Risks of Tianeptine
Table 59. Key Industry Trends of Tianeptine
Table 60. Tianeptine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tianeptine Distributors List
Table 63. Tianeptine Customer List
Table 64. Global Tianeptine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Tianeptine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tianeptine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Tianeptine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tianeptine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Tianeptine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tianeptine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Tianeptine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Servier Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 79. Servier Tianeptine Product Portfolios and Specifications
Table 80. Servier Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Servier Main Business
Table 82. Servier Latest Developments
Table 83. Lupin Limited Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 84. Lupin Limited Tianeptine Product Portfolios and Specifications
Table 85. Lupin Limited Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Lupin Limited Main Business
Table 87. Lupin Limited Latest Developments
Table 88. PharmaS Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 89. PharmaS Tianeptine Product Portfolios and Specifications
Table 90. PharmaS Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. PharmaS Main Business
Table 92. PharmaS Latest Developments
Table 93. Antibiotice Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 94. Antibiotice Tianeptine Product Portfolios and Specifications
Table 95. Antibiotice Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Antibiotice Main Business
Table 97. Antibiotice Latest Developments
Table 98. Serdia Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serdia Pharmaceuticals Tianeptine Product Portfolios and Specifications
Table 100. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Serdia Pharmaceuticals Main Business
Table 102. Serdia Pharmaceuticals Latest Developments
Table 103. Alvogen Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 104. Alvogen Tianeptine Product Portfolios and Specifications
Table 105. Alvogen Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Alvogen Main Business
Table 107. Alvogen Latest Developments
Table 108. Bausch Health Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bausch Health Tianeptine Product Portfolios and Specifications
Table 110. Bausch Health Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bausch Health Main Business
Table 112. Bausch Health Latest Developments
Table 113. Genefar B.V. Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 114. Genefar B.V. Tianeptine Product Portfolios and Specifications
Table 115. Genefar B.V. Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Genefar B.V. Main Business
Table 117. Genefar B.V. Latest Developments
Table 118. Arena Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 119. Arena Pharmaceuticals Tianeptine Product Portfolios and Specifications
Table 120. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Arena Pharmaceuticals Main Business
Table 122. Arena Pharmaceuticals Latest Developments
Table 123. Glenmark Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 124. Glenmark Tianeptine Product Portfolios and Specifications
Table 125. Glenmark Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Glenmark Main Business
Table 127. Glenmark Latest Developments
Table 128. Novartis Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Tianeptine Product Portfolios and Specifications
Table 130. Novartis Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Dongwha Pharm Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dongwha Pharm Tianeptine Product Portfolios and Specifications
Table 135. Dongwha Pharm Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dongwha Pharm Main Business
Table 137. Dongwha Pharm Latest Developments
Table 138. Liconsa SA Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 139. Liconsa SA Tianeptine Product Portfolios and Specifications
Table 140. Liconsa SA Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Liconsa SA Main Business
Table 142. Liconsa SA Latest Developments
Table 143. Mylan Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 144. Mylan Tianeptine Product Portfolios and Specifications
Table 145. Mylan Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Mylan Main Business
Table 147. Mylan Latest Developments
Table 148. Adamed Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 149. Adamed Tianeptine Product Portfolios and Specifications
Table 150. Adamed Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Adamed Main Business
Table 152. Adamed Latest Developments
Table 153. Neuraxpharm Arzneimittel Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 154. Neuraxpharm Arzneimittel Tianeptine Product Portfolios and Specifications
Table 155. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Neuraxpharm Arzneimittel Main Business
Table 157. Neuraxpharm Arzneimittel Latest Developments
Table 158. Grupo Insud Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 159. Grupo Insud Tianeptine Product Portfolios and Specifications
Table 160. Grupo Insud Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Grupo Insud Main Business
Table 162. Grupo Insud Latest Developments
Table 1. Tianeptine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tianeptine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Tianeptine Sales by Type (2018-2023) & (K Units)
Table 6. Global Tianeptine Sales Market Share by Type (2018-2023)
Table 7. Global Tianeptine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tianeptine Revenue Market Share by Type (2018-2023)
Table 9. Global Tianeptine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Tianeptine Sales by Application (2018-2023) & (K Units)
Table 11. Global Tianeptine Sales Market Share by Application (2018-2023)
Table 12. Global Tianeptine Revenue by Application (2018-2023)
Table 13. Global Tianeptine Revenue Market Share by Application (2018-2023)
Table 14. Global Tianeptine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Tianeptine Sales by Company (2018-2023) & (K Units)
Table 16. Global Tianeptine Sales Market Share by Company (2018-2023)
Table 17. Global Tianeptine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tianeptine Revenue Market Share by Company (2018-2023)
Table 19. Global Tianeptine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Tianeptine Producing Area Distribution and Sales Area
Table 21. Players Tianeptine Products Offered
Table 22. Tianeptine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tianeptine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Tianeptine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tianeptine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tianeptine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tianeptine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Tianeptine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tianeptine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tianeptine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tianeptine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Tianeptine Sales Market Share by Country (2018-2023)
Table 35. Americas Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tianeptine Revenue Market Share by Country (2018-2023)
Table 37. Americas Tianeptine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Tianeptine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Tianeptine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Tianeptine Sales Market Share by Region (2018-2023)
Table 41. APAC Tianeptine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tianeptine Revenue Market Share by Region (2018-2023)
Table 43. APAC Tianeptine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Tianeptine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Tianeptine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Tianeptine Sales Market Share by Country (2018-2023)
Table 47. Europe Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tianeptine Revenue Market Share by Country (2018-2023)
Table 49. Europe Tianeptine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Tianeptine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Tianeptine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Tianeptine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tianeptine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tianeptine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tianeptine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Tianeptine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tianeptine
Table 58. Key Market Challenges & Risks of Tianeptine
Table 59. Key Industry Trends of Tianeptine
Table 60. Tianeptine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tianeptine Distributors List
Table 63. Tianeptine Customer List
Table 64. Global Tianeptine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Tianeptine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tianeptine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Tianeptine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tianeptine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Tianeptine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tianeptine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Tianeptine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tianeptine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Tianeptine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Servier Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 79. Servier Tianeptine Product Portfolios and Specifications
Table 80. Servier Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Servier Main Business
Table 82. Servier Latest Developments
Table 83. Lupin Limited Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 84. Lupin Limited Tianeptine Product Portfolios and Specifications
Table 85. Lupin Limited Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Lupin Limited Main Business
Table 87. Lupin Limited Latest Developments
Table 88. PharmaS Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 89. PharmaS Tianeptine Product Portfolios and Specifications
Table 90. PharmaS Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. PharmaS Main Business
Table 92. PharmaS Latest Developments
Table 93. Antibiotice Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 94. Antibiotice Tianeptine Product Portfolios and Specifications
Table 95. Antibiotice Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Antibiotice Main Business
Table 97. Antibiotice Latest Developments
Table 98. Serdia Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serdia Pharmaceuticals Tianeptine Product Portfolios and Specifications
Table 100. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Serdia Pharmaceuticals Main Business
Table 102. Serdia Pharmaceuticals Latest Developments
Table 103. Alvogen Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 104. Alvogen Tianeptine Product Portfolios and Specifications
Table 105. Alvogen Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Alvogen Main Business
Table 107. Alvogen Latest Developments
Table 108. Bausch Health Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bausch Health Tianeptine Product Portfolios and Specifications
Table 110. Bausch Health Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bausch Health Main Business
Table 112. Bausch Health Latest Developments
Table 113. Genefar B.V. Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 114. Genefar B.V. Tianeptine Product Portfolios and Specifications
Table 115. Genefar B.V. Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Genefar B.V. Main Business
Table 117. Genefar B.V. Latest Developments
Table 118. Arena Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 119. Arena Pharmaceuticals Tianeptine Product Portfolios and Specifications
Table 120. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Arena Pharmaceuticals Main Business
Table 122. Arena Pharmaceuticals Latest Developments
Table 123. Glenmark Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 124. Glenmark Tianeptine Product Portfolios and Specifications
Table 125. Glenmark Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Glenmark Main Business
Table 127. Glenmark Latest Developments
Table 128. Novartis Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Tianeptine Product Portfolios and Specifications
Table 130. Novartis Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Dongwha Pharm Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dongwha Pharm Tianeptine Product Portfolios and Specifications
Table 135. Dongwha Pharm Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dongwha Pharm Main Business
Table 137. Dongwha Pharm Latest Developments
Table 138. Liconsa SA Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 139. Liconsa SA Tianeptine Product Portfolios and Specifications
Table 140. Liconsa SA Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Liconsa SA Main Business
Table 142. Liconsa SA Latest Developments
Table 143. Mylan Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 144. Mylan Tianeptine Product Portfolios and Specifications
Table 145. Mylan Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Mylan Main Business
Table 147. Mylan Latest Developments
Table 148. Adamed Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 149. Adamed Tianeptine Product Portfolios and Specifications
Table 150. Adamed Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Adamed Main Business
Table 152. Adamed Latest Developments
Table 153. Neuraxpharm Arzneimittel Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 154. Neuraxpharm Arzneimittel Tianeptine Product Portfolios and Specifications
Table 155. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Neuraxpharm Arzneimittel Main Business
Table 157. Neuraxpharm Arzneimittel Latest Developments
Table 158. Grupo Insud Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 159. Grupo Insud Tianeptine Product Portfolios and Specifications
Table 160. Grupo Insud Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Grupo Insud Main Business
Table 162. Grupo Insud Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tianeptine
Figure 2. Tianeptine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tianeptine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tianeptine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tianeptine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Tianeptine Sales Market Share by Type in 2022
Figure 12. Global Tianeptine Revenue Market Share by Type (2018-2023)
Figure 13. Tianeptine Consumed in Depression and Anxiety
Figure 14. Global Tianeptine Market: Depression and Anxiety (2018-2023) & (K Units)
Figure 15. Tianeptine Consumed in Irritable Bowel Syndrome
Figure 16. Global Tianeptine Market: Irritable Bowel Syndrome (2018-2023) & (K Units)
Figure 17. Global Tianeptine Sales Market Share by Application (2022)
Figure 18. Global Tianeptine Revenue Market Share by Application in 2022
Figure 19. Tianeptine Sales Market by Company in 2022 (K Units)
Figure 20. Global Tianeptine Sales Market Share by Company in 2022
Figure 21. Tianeptine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Tianeptine Revenue Market Share by Company in 2022
Figure 23. Global Tianeptine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Tianeptine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Tianeptine Sales 2018-2023 (K Units)
Figure 26. Americas Tianeptine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Tianeptine Sales 2018-2023 (K Units)
Figure 28. APAC Tianeptine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Tianeptine Sales 2018-2023 (K Units)
Figure 30. Europe Tianeptine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Tianeptine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Tianeptine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Tianeptine Sales Market Share by Country in 2022
Figure 34. Americas Tianeptine Revenue Market Share by Country in 2022
Figure 35. Americas Tianeptine Sales Market Share by Type (2018-2023)
Figure 36. Americas Tianeptine Sales Market Share by Application (2018-2023)
Figure 37. United States Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Tianeptine Sales Market Share by Region in 2022
Figure 42. APAC Tianeptine Revenue Market Share by Regions in 2022
Figure 43. APAC Tianeptine Sales Market Share by Type (2018-2023)
Figure 44. APAC Tianeptine Sales Market Share by Application (2018-2023)
Figure 45. China Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Tianeptine Sales Market Share by Country in 2022
Figure 53. Europe Tianeptine Revenue Market Share by Country in 2022
Figure 54. Europe Tianeptine Sales Market Share by Type (2018-2023)
Figure 55. Europe Tianeptine Sales Market Share by Application (2018-2023)
Figure 56. Germany Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Tianeptine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Tianeptine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Tianeptine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Tianeptine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Tianeptine in 2022
Figure 71. Manufacturing Process Analysis of Tianeptine
Figure 72. Industry Chain Structure of Tianeptine
Figure 73. Channels of Distribution
Figure 74. Global Tianeptine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Tianeptine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Tianeptine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Tianeptine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Tianeptine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Tianeptine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Tianeptine
Figure 2. Tianeptine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tianeptine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tianeptine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tianeptine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Tianeptine Sales Market Share by Type in 2022
Figure 12. Global Tianeptine Revenue Market Share by Type (2018-2023)
Figure 13. Tianeptine Consumed in Depression and Anxiety
Figure 14. Global Tianeptine Market: Depression and Anxiety (2018-2023) & (K Units)
Figure 15. Tianeptine Consumed in Irritable Bowel Syndrome
Figure 16. Global Tianeptine Market: Irritable Bowel Syndrome (2018-2023) & (K Units)
Figure 17. Global Tianeptine Sales Market Share by Application (2022)
Figure 18. Global Tianeptine Revenue Market Share by Application in 2022
Figure 19. Tianeptine Sales Market by Company in 2022 (K Units)
Figure 20. Global Tianeptine Sales Market Share by Company in 2022
Figure 21. Tianeptine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Tianeptine Revenue Market Share by Company in 2022
Figure 23. Global Tianeptine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Tianeptine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Tianeptine Sales 2018-2023 (K Units)
Figure 26. Americas Tianeptine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Tianeptine Sales 2018-2023 (K Units)
Figure 28. APAC Tianeptine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Tianeptine Sales 2018-2023 (K Units)
Figure 30. Europe Tianeptine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Tianeptine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Tianeptine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Tianeptine Sales Market Share by Country in 2022
Figure 34. Americas Tianeptine Revenue Market Share by Country in 2022
Figure 35. Americas Tianeptine Sales Market Share by Type (2018-2023)
Figure 36. Americas Tianeptine Sales Market Share by Application (2018-2023)
Figure 37. United States Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Tianeptine Sales Market Share by Region in 2022
Figure 42. APAC Tianeptine Revenue Market Share by Regions in 2022
Figure 43. APAC Tianeptine Sales Market Share by Type (2018-2023)
Figure 44. APAC Tianeptine Sales Market Share by Application (2018-2023)
Figure 45. China Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Tianeptine Sales Market Share by Country in 2022
Figure 53. Europe Tianeptine Revenue Market Share by Country in 2022
Figure 54. Europe Tianeptine Sales Market Share by Type (2018-2023)
Figure 55. Europe Tianeptine Sales Market Share by Application (2018-2023)
Figure 56. Germany Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Tianeptine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Tianeptine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Tianeptine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Tianeptine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Tianeptine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Tianeptine in 2022
Figure 71. Manufacturing Process Analysis of Tianeptine
Figure 72. Industry Chain Structure of Tianeptine
Figure 73. Channels of Distribution
Figure 74. Global Tianeptine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Tianeptine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Tianeptine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Tianeptine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Tianeptine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Tianeptine Revenue Market Share Forecast by Application (2024-2029)
